SIC
NVO

SJS Investment Consulting’s Novo Nordisk NVO Stock Holding History

SJS Investment Consulting’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Buy
320
+170
+113% +$7.3K ﹤0.01% 891
2026
Q1 		$5.51K Sell
150
-171
-53% -$8.1K ﹤0.01% 1013
2025
Q4 		$16.3K Buy
321
+171
+114% +$8.74K ﹤0.01% 680
2025
Q3 		$8.32K Sell
150
-4
-3% -$234 ﹤0.01% 641
2025
Q2 		$10.6K Hold
154
– – ﹤0.01% 337
2025
Q1 		$10.7K Buy
154
+4
+3% +$330 ﹤0.01% 357
2024
Q4 		$12.9K Hold
150
– – ﹤0.01% 324
2024
Q3 		$17.9K Hold
150
– – ﹤0.01% 294
2024
Q2 		$21.4K Sell
150
-410
-73% -$54.3K ﹤0.01% 259
2024
Q1 		$71.9K Buy
560
+410
+273% +$48.8K 0.01% 149
2023
Q4 		$15.5K Hold
150
– – ﹤0.01% 258
2023
Q3 		$13.6K Sell
150
-366
-71% -$32.2K ﹤0.01% 262
2023
Q2 		$41.8K Buy
516
+366
+244% +$29.9K 0.01% 164
2023
Q1 		$11.9K Hold
150
– – ﹤0.01% 270
2022
Q4 		$10.2K Sell
150
-974
-87% -$57.1K ﹤0.01% 284
2022
Q3 		$56K Buy
+1,124
New +$60.2K 0.02% 153
2022
Q1 		$25K Hold
458
– – 0.01% 271
2021
Q4 		$26K Buy
+458
New +$24.8K 0.01% 239

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

SJS Investment Consulting's NVO Position: Q2 2026 in Review

SJS Investment Consulting increased its Novo Nordisk (NVO) stake by 113% in Q2 2026, buying an estimated $7.3K and bringing the position to 320 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

SJS Investment Consulting first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $71.9K in Q1 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SJS Investment Consulting held 320 shares of Novo Nordisk worth $15.3K as of Q2 2026.
  • SJS Investment Consulting bought 170 Novo Nordisk shares in Q2 2026, an estimated $7.3K.
  • Novo Nordisk made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #891 holding.
  • SJS Investment Consulting first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • SJS Investment Consulting's Novo Nordisk position peaked at $71.9K in Q1 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.